MétaCan
Menu
Back to cohort
Record W2559765592 · doi:10.1093/ofid/ofw172.1386

Activity of Imipenem-Relebactam (MK-7655) Against Enterobacteriaceae and Pseudomonas aeruginosa From Intraabdominal Infections in North America—SMART 2015

2016· article· en· W2559765592 on OpenAlexaboutno aff
Meredith Hackel, Katherine Young, Mary Motyl, Dan Sahm

Bibliographic record

VenueOpen Forum Infectious Diseases · 2016
Typearticle
Languageen
FieldImmunology and Microbiology
TopicAntibiotic Use and Resistance
Canadian institutionsnot available
Fundersnot available
KeywordsEnterobacteriaceaePseudomonas aeruginosaImipenemMedicineMicrobiologyVirologyBiologyBacteriaEscherichia coliGeneticsGene

Abstract

fetched live from OpenAlex

Background. Relebactam (formerly MK-7655) (REL) is a newly developed beta-lactamase inhibitor of class A and class C carbapenemases. REL restores the in vitro activity of imipenem (IMI) against Enterobacteriaceae, including those producing KPC, and Pseudomonas aeruginosa (PA). In this study we evaluated the ability of REL to restore IMI susceptibility to a collection of gram-negative isolates from intraabdominal infections (IAI) from North America collected as part of the 2015 SMART surveillance program. Methods. Twenty-six hospitals in the United States (19) and Canada (7) collected up to 100 consecutive gram-negative pathogens from IAI. MICs were determined for 189 PA and 1607 nonproteae Enterobacteriaceae (NPE) using CLSI broth microdilution. Proteae were excluded due to intrinsic nonsusceptibility to IMI. REL was tested at a fixed concentration of 4 µg/mL in combination with IMI. The percentage susceptible (S) was assessed using CLSI breakpoints. IMI S breakpoints of ≤1 µg/mL (NPE) and ≤2 µg/mL (PA) were applied to IMI/REL. Results. The cumulative percentage of isolates at each IMI and IMI/REL MIC is shown in the table. Shaded area indicates susceptible by CLSI 2016 imipenem breakpoint; MIC90 bolded; NPE, nonproteae Enterobacteriaceae; IMI, imipenem; REL, relebactam; NS, non-susceptible Among 189 PA, 78% (149) were S to IMI; of the 40 non-susceptible (NS) isolates, 32 (80%) were rendered S by the addition of REL, for a final 96% S. Among 1607 NPE, 98% (1573) were S to IMI; of the 34 NS isolates, 24 (71%) were rendered S by the addition of REL, for a final 99% S. Conclusion. Relebactam exhibited strong potential for restoring the in vitro activity of IMI against many IAI pathogens otherwise NS to carbapenems. Further development of this compound could provide a valuable therapeutic option for treating infections caused by resistant gram-negative bacilli. Disclosures. M. Hackel, IHMA, Inc: Independent Contractor, Research support K. Young, Merck & Co, Inc: Employee, Salary M. Motyl, Merck & Co, Inc: Employee, Salary D. Sahm, IHMA, Inc: Independent Contractor, Research support

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.082
Threshold uncertainty score0.801

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.228
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicAntibiotic Use and ResistanceFrench-language works237,207